IKBKB and marginal zone lymphoma: IKBKB was recognized as a cancer gene by COSMIC based on the finding of IKBKB activating mutations in Lys175 in around 8% of splenic marginal zone lymphomas of B cells; this mutation renders a constitutively active IKKβ protein [74].